Q3 2019 Holdings
Filed 2019-11-14 | 109 holdings | $365.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $144.0M | 6,706,268 | 39.4% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $51.3M | 11,521,102 | 14.0% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $42.1M | 1,543,790 | 11.5% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $38.9M | 2,587,953 | 10.6% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $24.0M | 3,253,923 | 6.6% |
| Bio-Rad Laboratories Inc Shs-A-(BIO) | COM | 090572207 | $21.6M | 65,000 | 5.9% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $16.3M | 3,085,458 | 4.4% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $9.1M | 295,000 | 2.5% |
| Alector Inc(ALEC) | COM | 014442107 | $7.4M | 511,731 | 2.0% |
| Alphatec Holdings Inc(ATEC) | COM NEW | 02081G201 | $4.3M | 850,000 | 1.2% |
| Cryolife Inc(AORT) | COM | 228903100 | $1.4M | 50,000 | 0.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.1M | 53,879 | 0.3% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $866.0K | 30,738 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $365.8K | 4,059,900 | 0.1% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $285.1K | 5,875,726 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $258.2K | 3,314,606 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $200.5K | 11,014,702 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $197.4K | 24,609,700 | 0.1% |
| Zogenix Inc | COM | 98978L204 | $130.7K | 3,264,152 | 0.0% |
| Athenex Inc(ATNXEUR) | COM | 04685N103 | $130.6K | 10,735,245 | 0.0% |
| Amarin Corporation PLC | SPONS ADR NEW | 023111206 | $115.8K | 7,636,079 | 0.0% |
| Dova Pharmaceuticals Inc(DOVA) | COM | 25985T102 | $103.7K | 3,708,705 | 0.0% |
| Meiragtx Holdings PLC(MGTX) | COM | G59665102 | $102.6K | 6,433,277 | 0.0% |
| Quotient LTD | SHS | G73268107 | $83.8K | 10,789,054 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $83.8K | 974,773 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $69.8K | 6,749,803 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $69.8K | 3,217,522 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $64.9K | 883,264 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $59.2K | 2,388,890 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $59.0K | 1,130,511 | 0.0% |
| Verrica Pharmaceuticals Inc | COM | 92511W108 | $50.3K | 3,410,412 | 0.0% |
| Neptune Wellness Solutions Inc | COM | 64079L105 | $47.8K | 13,436,906 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM | 91822J103 | $46.0K | 45,951,556 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $45.1K | 3,135,199 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $43.6K | 953,129 | 0.0% |
| Retrophin Inc | COM | 761299106 | $37.9K | 3,270,571 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $37.6K | 2,905,000 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $34.1K | 1,704,330 | 0.0% |
| Foamix Pharmaceuticals LTD | COM | M46135105 | $34.1K | 11,203,881 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $33.9K | 350,000 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COM | 48283N106 | $33.2K | 13,165,746 | 0.0% |
| DBV Technologies SA | SPONSORED ADR | 23306J101 | $31.0K | 3,609,084 | 0.0% |
| Protagonist Therapeutics Inc | COM | 4366E1029 | $24.9K | 2,071,297 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $24.7K | 686,992 | 0.0% |
| Establishment Labs Holdings Inc(ESTA) | COM | G31249108 | $23.8K | 1,260,528 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $23.1K | 1,198,182 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $23.0K | 1,977,412 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $22.5K | 597,190 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $22.3K | 854,940 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $21.6K | 608,000 | 0.0% |